Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-025417

Director sold 1,155 shares at $84.89 ($98,045)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2020-09-14 Sale −1,155 $84.89 $98,045 530,190 I: show line 1 in the form
Open-market sales · 1,155 sh · avg $84.89 · $98,045
Loading xslF345X03/doc4.xml…